GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » Total Equity

MBCOF (Marvel Biosciences) Total Equity : $-2.47 Mil (As of Jan. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Marvel Biosciences Total Equity?

Marvel Biosciences's total equity for the quarter that ended in Jan. 2025 was $-2.47 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Marvel Biosciences Total Equity Historical Data

The historical data trend for Marvel Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Total Equity Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
Total Equity
0.09 1.88 0.15 -1.30 -2.06

Marvel Biosciences Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.83 -2.02 -2.06 -2.24 -2.47

Marvel Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Marvel Biosciences's Total Equity for the fiscal year that ended in Jul. 2024 is calculated as

Total Equity=Total Assets(Q: Jul. 2024 )-Total Liabilities(Q: Jul. 2024 )
=0.358-2.419
=-2.06

Marvel Biosciences's Total Equity for the quarter that ended in Jan. 2025 is calculated as

Total Equity=Total Assets(Q: Jan. 2025 )-Total Liabilities(Q: Jan. 2025 )
=0.152-2.617
=-2.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Total Equity Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » Total Equity
Comparable Companies
XCNQ:ASEP XCNQ:LOBE TSXV:QPT TSX:APLI XCNQ:RIZE TSXV:XRTX TSXV:IOT TSXV:IBO TSXV:CYTO XCNQ:NURL VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
MRVL:Canada
Address
505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Website
https://www.marvelbiotechnology.com
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.